Opportunities and obstacles in the implementation of barrier technology

Area of Science:

• Pharmaceutical Technology
• Containment Engineering

Background:

• The Isolation Technology Users Group (ITUG) meeting in December 1993 convened over 100 users and suppliers.
• ITUG's subsequent integration into the Parenteral Drug Association (PDA) aims to foster open communication.
• This transition seeks to remove commercial barriers, promoting a unified industry approach to isolation technology.

Purpose of the Study:

• To facilitate the exchange of ideas and information regarding isolation technology.
• To encourage industry-wide collaboration among users and suppliers.
• To address obstacles and capitalize on opportunities within isolation technology.

Main Methods:

• Keynote address delivered at the ITUG meeting.
• Discussion and information exchange among attendees.
• Formation of a special interest group within the Parenteral Drug Association.

Main Results:

• Over 100 professionals attended, representing diverse perspectives on isolation technology.
• A decision was made to integrate ITUG within the PDA, opening participation to all PDA members.
• The integration is expected to promote a more collaborative and less commercially influenced environment.

Conclusions:

• Isolation technology holds substantial promise for the pharmaceutical industry.
• Enhanced collaboration between users and suppliers is crucial for advancing barrier systems.
• The integration of ITUG within PDA is anticipated to accelerate progress in the field.